Related Experiment Videos
Different thallium-201 single-photon emission tomographic patterns in benign and aggressive meningiomas
E Tedeschi1, A Soricelli, A Brunetti
1Dipartimento di Diagnostica per Immagini-Centro CNR per la Medicina Nucleare, Napoli, Italy.
European Journal of Nuclear Medicine
|November 1, 1996
Summary
This study introduces a fast method using thallium-201 (201Tl) SPECT scans to predict intracranial meningioma aggressiveness preoperatively. Higher early to late 201Tl ratios indicate malignant tumors, aiding in surgical planning.
Area of Science:
- Neuro-oncology
- Nuclear Medicine
- Radiology
Background:
- Intracranial meningiomas require preoperative assessment of biological behavior.
- Differentiating aggressive from benign meningiomas preoperatively is clinically significant.
Purpose of the Study:
- To evaluate the potential of thallium-201 (201Tl) SPECT imaging for preoperative assessment of intracranial meningioma aggressiveness.
- To establish an index of tumor aggressiveness using early and delayed 201Tl uptake patterns.
Main Methods:
- Prospective study of 22 patients with intracranial meningiomas using computed tomography/magnetic resonance imaging.
- Single-photon emission tomography (SPET) with intravenous 201Tl administration and rapid acquisition protocol (early and delayed scans).
- Calculation of 201Tl concentration ratios in tumor and contralateral brain tissue.
Main Results:
- Malignant meningiomas showed a significantly higher ratio of early (2-4 min) to delayed (14-16 min) 201Tl concentration compared to benign tumors (1.14±0.31 vs. 0.56±0.13, P <0.01).
- Delayed scans did not effectively distinguish between tumor groups.
- Recurrent meningiomas exhibited imaging characteristics similar to malignant lesions.
Conclusions:
- Comparative assessment of intratumoral 201Tl concentration at early and delayed time points offers a rapid, non-invasive method for preoperative differentiation of meningioma aggressiveness.
- This SPET-based approach may aid in surgical planning and patient management for intracranial meningiomas.